| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9092c90fd86471f706dcc2ab78cb6295
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_63f293fb56e28b0c797fd31eb8c33ad4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_62f4f46129e80ef907c188099adbb95a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_de2584bef6b987ea987eb0bcc8d95afa |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-071 |
| filingDate |
2021-01-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_76d79236a24a957ef6f0cf298021bbd9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f7e99756a44464930323c385fa22cad1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_157f5259493279bf0d69e92bfd457f71
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_677a75881e16b482342b8648f3e19080 |
| publicationDate |
2021-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2021146648-A1 |
| titleOfInvention |
Compositions for managing chronic obstructive pulmonary disease |
| abstract |
The invention discloses a composition comprising not less than 20% w/w bisdemethoxycurcumin for regeneration of alveolar cells damaged in emphysematous conditions and for the therapeutic management of chronic obstructive pulmonary disease and acute respiratory distress syndrome. The composition further comprises 10-35% w/w demethoxycurcumin and 10-45% wVw curcumin. The composition is very suitable for treating COPD and ARDS due to viral infections, specifically COVID 19 and for improving lung lunction during prognosis. |
| priorityDate |
2020-01-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |